Identification |
Name: | L-Leucine,N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]- |
Synonyms: | L-Leucine,N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-, [S-(R*,S*)]-;(-)-Bestatin;Bestatin;NK 421;NSC 265489;Ubenimex; |
CAS: | 58970-76-6 |
EINECS: | 261-529-2 |
Molecular Formula: | C16H24N2O4 |
Molecular Weight: | 308.38 |
InChI: | InChI=1/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.197 g/cm3/sup> |
Stability: | Stable at normal temperatures and pressures. |
Refractive index: | 1.557 |
Solubility: | Soluble |
Appearance: | White crystalline powder |
Biological Activity: | Aminopeptidase inhibitor (K i = 0.001-90 mM); inhibits enkephalin metabolism and leukotriene A 4 hydrolase. Inhibits tumor cell proliferation. |
Usage: | An aminopeptidase inhibitor used in combination with chemotherapeutics for the maintenance and enhancement of complete remission of acute non-lymphocytic leukemia in adults. |
Safety Data |
|
|